GlassScriptPhysician profile
Ashfaq A Khan
NPI 1093754731
$2,186.10
in general payments reported to CMS, 2019-2025
14 companies · $49.41 in 2025
The $49.41 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.65 · 2020: $34.89 · 2021: $777 · 2022: $473 · 2023: $712 · 2024: $104 · 2025: $49.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $865.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $583.76 | 2020-2024 | |
| Abiomed | $335.75 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $329.51 | 2021-2024 | Lifevest |
| Boston Scientific Corporation | $299.40 | 2021-2025 | Watchman Flx, Watchman Access System |
| Acist Medical Systems, INC. | $158.59 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $143.75 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.13 | 2023 | Jardiance |
| Merck Sharp & Dohme LLC | $104.71 | 2022-2023 | Verquvo |
| Cvrx, INC. | $36.52 | 2021-2023 | Barostim Neo System |
| Itamar Medical INC | $23.43 | 2023 | Watchpatone |
| Medtronic Vascular, INC. | $15.88 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.60 | 2021 | |
| Scpharmaceuticals INC. | $14.36 | 2023 | |
| Avinger INC. | $13.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashfaq Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.